The distribution of the neurokinins in both the central and peripheral nervous systems has been reported to be similar to that of substance P, the prototype of the tachykinin family. 2 The concentration of these peptides in perivascular nerve terminals impinging upon the resistance vessels of the peripheral circulation has led to the suggestion that they play a role in the modulation of the circulation. 3'4 Additionally, evidence is accumulating which suggests that alterations in tachykinin levels may play a role in a multitude of pathophysiological conditions. 3 (Table 1 ).
In the neurokinin B experiments, the intraarterial infusion of norepinephrine resulted in a significant increase in lymphatic perfusion pressure from a control value of 5.6 -t-0.6 mmHg to a peak pressure of 12.1 -+-1.4 mmHg (Figure 2 ). Systemic pressure, forelimb perfusion, skin small artery and vein pressures were all significantly increased ( Table  2 ). The intralymphatic infusion of neurokinin B during the continued infusion of norepinephrine resulted in a significant decrease in lymphatic perfusion pressure from its pre-neurokinin level of 11.9 q-1.3 mmHg to a nadir of 9.9 _+ 1.1 mmHg (Figure 2 
